STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability

by Luo, Tuoping, Masson, Kristina, Jaffe, Jacob D., Silkworth, Whitney, Lee, Nathan Ross, Scherer, Christina A., Scholl, Claudia, Frohling, Stefan, Stern, Andrew M., Schreiber, Stuart L., Golub, Todd R., Carr, Steven A
Published 2012